Avanos Medical (AVNS) Return on Capital Employed Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 3,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,246.00 |
| Dec 31, 2025 | 2,517.00 |
| Sep 30, 2025 | -5,562.00 |
| Jun 30, 2025 | -5,170.00 |
| Mar 31, 2025 | -4,020.00 |
| Dec 31, 2024 | -3,225.00 |
| Sep 30, 2024 | 169.00 |
| Jun 30, 2024 | 19.00 |
| Mar 31, 2024 | -111.00 |
| Dec 31, 2023 | -274.00 |
| Sep 30, 2023 | 6.00 |
| Jun 30, 2023 | 140.00 |
| Mar 31, 2023 | 324.00 |
| Dec 31, 2022 | 567.00 |
| Sep 30, 2022 | 477.00 |
| Jun 30, 2022 | 443.00 |
| Mar 31, 2022 | 293.00 |
| Dec 31, 2021 | 44.00 |
| Sep 30, 2021 | -392.00 |
| Jun 30, 2021 | -302.00 |
| Mar 31, 2021 | -217.00 |
| Dec 31, 2020 | 41.00 |
| Sep 30, 2020 | 357.00 |
| Jun 30, 2020 | 78.00 |
| Mar 31, 2020 | -84.00 |
| Dec 31, 2019 | -353.00 |
| Sep 30, 2019 | -421.00 |
| Jun 30, 2019 | -152.00 |
| Mar 31, 2019 | 70.00 |
| Dec 31, 2018 | 245.00 |
| Sep 30, 2018 | 1,240.00 |
| Jun 30, 2018 | 983.00 |
| Mar 31, 2018 | 715.00 |
| Dec 31, 2017 | 367.00 |
| Sep 30, 2017 | -3,067.00 |
| Jun 30, 2017 | -211.00 |
| Mar 31, 2017 | -48.00 |
| Dec 31, 2016 | 195.00 |
| Sep 30, 2016 | 3,813.00 |
| Jun 30, 2016 | -1,298.00 |
| Mar 31, 2016 | -1,180.00 |
| Dec 31, 2015 | -1,247.00 |